8 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... #Oral #Anticoagulant ... Anticoagulation #Dabigatran #Apixaban ... #Loading #DVT #Pharmacology ... #Hematology
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... Table #DOAC ... Anticoagulation #VTE ... #Management #Pharmacology ... #Comparison #Table
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Rivaroxaban Oral ... patients with VTE ... patients with normal ... rivaroxaban for VTE ... #Pharmacology
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... #DOAC #Dosing #Oral ... Anticoagulation #Comparison ... #Table #Pharmacology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... direct-acting oral ... for appropriate dosing ... direct-acting oral ... Anticoagulation #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... bleeding risk during ... risk of recurrent VTE ... DOAC, direct oral ... Anticoagulation #Management #Hematology
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
direct acting oral ... clearance (calculated using ... per treatment table ... inhibitor) • Apixaban ... Management #Treatment #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
then be excreted using ... transitioning to oral ... #differential #algorithm ... cardiology #treatment #table ... icu #clinical #pharmacology